Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03591510
Title A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

acute myeloid leukemia

Therapies

Cytarabine

Cytarabine + Etoposide

Cytarabine + Mitoxantrone

Cytarabine + Fludarabine + Idarubicin

Cytarabine + Daunorubicin + Fludarabine

Cytarabine + Daunoxome + Fludarabine

Midostaurin

Age Groups: child
Covered Countries USA

Additional content available in CKB BOOST